News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Analyst action
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
ASPI's quarterly revenue increased to $5.1 million due to acquisitions and new segments, while its net loss from continuing operations narrowed to $34.0 million. The company completed the Renergen acquisition, diversifying into helium and LNG, and improved its liquidity, though it faces integration, regulatory, …
Aspire Biopharma (NASDAQ: ASBP) reported significantly reduced net losses in the first half of 2026, dropping to $4.49 million from $17.92 million a year prior, largely due to lower stock-based compensation and financing costs. The company also substantially improved its balance sheet, moving from …
Aspire Biopharma Holdings, Inc. announced its participation in Sidoti & Company's Micro-Cap Virtual Investor Conference on August 19-20, 2026. Management will host one-on-one meetings and discuss its clinical pipeline and recent acquisition of Dura Driver Control Systems. The presentation is scheduled for August 19, …
Kaspi.kz (KSPI) reported strong revenue growth in H1 2026, reaching KZT 2.19 trillion, but net income remained flat at KZT 511 billion due to significantly increased costs and operating expenses. The company's Super App-driven financial and retail ecosystem continues to scale, but rising cost …
ASP Isotopes (ASPI) plans to expand its isotope production, radiopharmacy, and helium businesses, targeting commercial deliveries of stable isotopes by the second half of 2026. The company is developing proprietary enrichment technologies and expects its Renergen platform to begin Phase 1 helium production by …
Kaspi.kz, a Kazakhstani fintech and e-commerce operator, reported strong 2Q 2026 results with 15% year-on-year revenue growth and stable net income, driven by its Super App, new Kasper AI assistant, and e-commerce segment. The company also expanded into Türkiye by acquiring and rebranding Rabobank …
This article provides comprehensive financial data for Joint Stock Company Kaspi.kz (ADR) (KSPI), including live share price, performance metrics, fundamentals, valuation, and peer comparisons. It also details quarterly and annual profit & loss statements, cash flow, and global institutional holdings. The content aims to …
Aspire Biopharma Holdings, Inc. announced its successful participation in CPHI Frankfurt, engaging in strategic discussions with global pharmaceutical companies regarding its sublingual high-dose aspirin. The company conducted numerous meetings with major industry players to explore technical collaboration and licensing opportunities for its lead product …
Image source: The Motley Fool. DATE Monday, Aug. 10, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Investor Relations - David FergusonChief Executive Officer and Co-Founder - Mikheil LomtadzeDeputy Chief Executive Officer - Tengiz MosidzeDeputy Chief Executive Officer - Yuri Didenko TAKEAWAYS Revenue -- KZT …
Kaspi.kz JSC (KSPI) shares increased by 4.4% to $94.00, yet the stock is considered "Significantly Undervalued" with a GF Value™ estimate of $229.46. The company boasts a strong GF Score™ of 85/100, driven by high profitability and growth scores, and is supported by positive …
This article first appeared on GuruFocus. Revenue: Reported revenue up 15% in the second quarter, driven by e-commerce and fintech revenue growth. Adjusted EBITDA: Up 5%, impacted by higher rates and investments into Turkey. Net Income: Flat, reflecting pressures on EBITDA and regulatory changes. …
This article reports on the filing of a Form 8K by Aspire Biopharma Holdings Inc. for August 10. The filing indicates a significant event or change at the company, as per SEC regulations. The content is brief, primarily serving as an announcement of the …
Kaspi.kz is set to hold an extraordinary shareholder meeting on September 9, 2026, in Almaty to vote on a proposed dividend of KZT 1,000 per common share. A repeat meeting is scheduled for September 10, 2026, if a quorum is not reached. The record …
Aspire Biopharma has completed its acquisition of specified subsidiaries and assets from FireFish, a move aimed at expanding its business. To facilitate the closing, an escrow agreement was established on August 6, 2026, making the acquisition automatic upon payment. Concurrently, Aspire Biopharma secured $3.0 …
Aspire Biopharma has completed its acquisition of Dura Driver Control Systems (DCS), a tier-one automotive supplier, for $30 million in cash. This acquisition is a strategic move to transform Aspire into a diversified, high-revenue enterprise, leveraging DCS's global manufacturing presence, extensive intellectual property, and …
Kaspi.kz announced strong financial results for 2Q and 1H 2026, with revenue increasing by 15% year-over-year and adjusted EBITDA up 5%. The company proposes an 18% increase in its quarterly dividend to KZT1,000 per ADS, reflecting confidence in future growth. A significant highlight is …
JSC Kaspi.kz has announced an Extraordinary General Meeting of Shareholders for September 9, 2026, to discuss its agenda and a proposed dividend of 1,000 KZT per common share. The record date for eligible shareholders is September 8, 2026, with a contingency plan for a …
Aspire Biopharma Holdings (NASDAQ: ASBP) has completed its $30 million acquisition of Dura Driver Control Systems (DCS), marking its entry into the automotive and mobility-control market. The deal makes DCS a wholly-owned subsidiary, expected to add significant revenue, earnings, and cash flow to Aspire's …
Aspire Biopharma Holdings, Inc. announced the launch of its BUZZ BOMB(TM) Convenience Store Pack, expanding its retail presence in the energy category. BUZZ BOMB(TM) is a dry powder caffeine product delivered in single-serving stick packs designed for sublingual use, offering a rapid caffeine boost …
Search by ticker symbol or company name and select a result to open its chart.